COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME

COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME

Aim. To compare effects of enalapril in combination with long-acting nifedipine or moxonidine on blood pressure (BP), myocardial mass and diastolic function of left ventricular, lipid and carbohydrate metabolism, platelet aggregation in patients with arterial hypertension (HT) and metabolic syndrome...

Full description

Bibliographic Details
Main Authors:	E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	metabolic syndrome arterial hypertension platelet aggregation enalapril long-acting nifedipine moxonidine combined therapy
Online Access:	https://www.rpcardio.online/jour/article/view/1113

Similar Items

Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome
by: N. M. Krasnova, et al.
Published: (2008-06-01)

POSSIBILITIES OF PROLONGED BLOOD PRESSURE MONITORING IN ASSESSMENT OF THE EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN EMERGENCY CARE
by: V. V. Ruksin, et al.
Published: (2022-04-01)

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
by: - Giuseppe Derosa, et al.
Published: (2009-03-01)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
by: Yu V Zhernakova, et al.
Published: (2015-03-01)

COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY
by: S. V. Nedogoda
Published: (2016-12-01)

ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME
by: E. M. Idrisova, et al.
Published: (2016-01-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

Clinical and Pharmacological Approaches to the Prescription of Centrally Acting Antihypertensive Drugs for Uncontrolled Arterial Hypertension
by: A. V. Strygin, et al.
Published: (2020-11-01)

Treatment of hypertension in overweight patients
by: V G Kukes, et al.
Published: (2015-09-01)

Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study
by: Eleni Karlafti, et al.
Published: (2022-01-01)

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS
by: A. M. Shilov, et al.
Published: (2015-09-01)

Combined antihypertensive therapy in metabolic syndrome patients
by: M. D. Mamedov
Published: (2006-08-01)

THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Hypertension treatment features in perimenopausal women
by: Yu V Zhernakova, et al.
Published: (2014-03-01)

The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects
by: S R Gilyarevsky
Published: (2014-09-01)

Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis
by: S N Tereshchenko, et al.
Published: (2013-03-01)

METABOLIC EFFECTS OF VARIOUS ANTIHYPERTENSIVE DRUG COMBINATIONS
by: E. E. Alimova, et al.
Published: (2012-12-01)

The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy
by: A S Ametov, et al.
Published: (2004-12-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION
by: O. D. Ostroumova, et al.
Published: (2015-05-01)

Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines
by: A V Rodionov
Published: (2013-06-01)

Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
by: Viktoriya Borisovna Mychka, et al.
Published: (2009-03-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

Enalapril and endothelial function in arterial hypertension patients of various age
by: L. I. Katelnitskaya, et al.
Published: (2005-12-01)

Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients
by: Macedo Cristiano Ricardo Bastos de, et al.
Published: (2001-01-01)

Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)
by: O. D. Ostroumova, et al.
Published: (2021-03-01)

COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

INFLUENCE OF THE COMBINED ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH METABOLIC SYNDROME
by: E. M. Idrisova, et al.
Published: (2016-01-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

Comparison effectiveness of use antihypertensive in preeclampsia patient in RSUD Panembahan Senopati Bantul
by: Andriana Sari, et al.
Published: (2023-07-01)

COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-08-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2010-06-01)

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
by: F. E. Khebodarov, et al.
Published: (2009-10-01)

METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES
by: M. E. Statsenko, et al.
Published: (2015-09-01)

COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS
by: O. M. Moiseeva, et al.
Published: (2016-01-01)

Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment
by: G. V. Ramenskaya, et al.
Published: (2019-01-01)

RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION
by: M. M. Batyushin, et al.
Published: (2015-12-01)

TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS
by: S. V. Malchikova, et al.
Published: (2016-01-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY)
by: T. G. Tolstikova, et al.
Published: (2016-01-01)